See-through “Get Low” leggings jolt Lululemon stock as quality questions return
21 January 2026
2 mins read

See-through “Get Low” leggings jolt Lululemon stock as quality questions return

New York, January 21, 2026, 08:23 EST — Premarket

  • Before the bell, Lululemon shares ticked up following a sharp drop in the previous session.
  • The company halted online sales of its new “Get Low” workout line following complaints that the leggings were see-through.
  • Governance concerns and a CEO transition are rattling investors.

Lululemon Athletica shares edged up about 0.3% in premarket trading Wednesday, rebounding slightly after a 6.5% drop the day before that pushed the stock to close at $188.76. The selloff came amid backlash over the company’s new “Get Low” workout line. 1

The online pause hits especially hard for Lululemon, given their focus on performance fabric and premium pricing. If customers start doubting the product, returns spike, foot traffic drops, and margins take a hit soon after.

The stock has tumbled close to 50% in the last year, making investors skittish. On top of that, the brand faces fresh backlash over sheerness issues and quality control concerns. 2

Lululemon has halted online sales in North America to assess early customer reactions, though the collection is still available in stores. A spokesperson described the move as a “temporary pause” to gather “initial guest feedback” and offer product education, with plans to resume online sales shortly. Morningstar analyst David Swartz flagged the incident as highlighting “issues with product development.” 3

The product setback coincides with a proxy battle for control of the board. Founder Chip Wilson is campaigning to oust private equity firm Advent from Lululemon’s board, Semafor reported, though Reuters said it couldn’t immediately verify that claim. Wilson owned a 4.27% stake as of December 2025, according to Reuters’ data, and has made clear that any deal would mean two longtime directors, including board chair David Mussafer, must resign. 4

Lululemon is preparing for a leadership change. According to a Dec. 11 filing, CEO Calvin McDonald will step down on Jan. 31. Board chair Marti Morfitt will take on the role of executive chair, while CFO Meghan Frank and chief commercial officer Andre Maestrini will act as interim co-CEOs during the search for a new permanent leader. 5

Last week, the company said it anticipates fourth-quarter fiscal 2025 revenue and earnings per share to land near the top of its earlier forecast ranges, following a strong holiday season. CFO Meghan Frank confirmed the expectation to reach “the higher end” of its previously stated guidance. 6

But the situation is double-edged. If the online pause stretches out or complaints about sheerness mount, Lululemon could face new brand damage just when it can’t afford missteps. On top of that, governance issues might steal focus, even if sales remain steady.

Traders will be watching closely for a couple of key signs: if “Get Low” makes a swift, low-key comeback online, and whether management hints at a wider product overhaul. Fresh filings or comments linked to the proxy battle could swing the stock as much as the leggings themselves.

Investors are now zeroed in on Jan. 31, when the interim co-CEOs step in. That day might reveal new insights into the CEO hunt and the company’s strategy for speeding up product development.

Stock Market Today

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

Reckitt share price ends week near a one-year high as RKT investors eye special dividend and March results

7 February 2026
London, Feb 7, 2026, 08:16 GMT — Market closed. Reckitt Benckiser Group (RKT.L) shares ended Friday at 6,400 pence, down 0.2%, after touching a one-year high of 6,432 pence. About 2.6 million shares changed hands. 1 The stock is now trading through the tail-end of a chunky one-off cash return. Reckitt has set a 235 pence-a-share special dividend for Feb. 20 and is pairing it with a 24-for-25 share consolidation to keep the quoted share price and per-share metrics broadly comparable after the payout. 2 In the wider market, Britain’s FTSE 100 finished Friday up 0.6%, with gains in heavyweight
GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Sandisk stock price rises again before the open as Citi lifts target, with Jan. 29 earnings looming
Previous Story

Sandisk stock price rises again before the open as Citi lifts target, with Jan. 29 earnings looming

IAMGOLD stock price jumps in premarket after record 2025 output and new 2026 targets
Next Story

IAMGOLD stock price jumps in premarket after record 2025 output and new 2026 targets

Go toTop